<SEC-DOCUMENT>0001654954-19-013637.txt : 20191205
<SEC-HEADER>0001654954-19-013637.hdr.sgml : 20191205
<ACCEPTANCE-DATETIME>20191205163032
ACCESSION NUMBER:		0001654954-19-013637
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20191203
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20191205
DATE AS OF CHANGE:		20191205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celcuity Inc.
		CENTRAL INDEX KEY:			0001603454
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38207
		FILM NUMBER:		191270688

	BUSINESS ADDRESS:	
		STREET 1:		16305 36TH AVENUE N
		STREET 2:		SUITE 100
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55446
		BUSINESS PHONE:		763-392-0767

	MAIL ADDRESS:	
		STREET 1:		16305 36TH AVENUE N
		STREET 2:		SUITE 100
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celcuity LLC
		DATE OF NAME CHANGE:	20140324
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>celc_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2019 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 4px solid #000000; border-bottom: 1px solid #000000">
<!--style header--><br></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
UNITED STATES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SECURITIES AND EXCHANGE COMMISSION</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Washington, D.C. 20549</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 32px">&#xA0;<font style="font-weight: bold">FORM
8-K</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<font style="font-weight: bold">CURRENT
REPORT</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Pursuant to Section&#xA0;13 or 15(d) of the</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Securities Exchange Act of 1934</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Date of Report (Date of earliest event reported): December 3,
2019</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 32px">
Celcuity Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Exact name of Registrant as Specified in its Charter)</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;&#xA0;<br>
</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Delaware</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
001-38207</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
82-2863566</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(State or Other Jurisdiction of Incorporation)</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Commission File Number)</font></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(IRS Employer Identification No.)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
16305 36th Avenue North; Suite 100&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Minneapolis, Minnesota 55446&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Address of Principal Executive Offices and Zip Code)</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(763) 392-0767&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Registrant&#x2019;s telephone number, including area
code)</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Not Applicable</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Former Name or Former Address, if Changed Since Last
Report)</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2610;</font></div>
</td>
<td style="vertical-align: bottom; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Written
communications pursuant to Rule&#xA0;425 under the Securities Act
(17 CFR 230.425)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2610;</font></div>
</td>
<td style="vertical-align: bottom; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Soliciting
material pursuant to Rule&#xA0;14a-12 under the Exchange Act (17
CFR 240.14a-12)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2610;</font></div>
</td>
<td style="vertical-align: bottom; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pre-commencement
communications pursuant to Rule&#xA0;14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 3%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px">&#x2610;</font></div>
</td>
<td style="vertical-align: bottom; width: 97%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pre-commencement
communications pursuant to Rule&#xA0;13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Securities
registered pursuant to Section 12(b) of the Act:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: bottom; width: 37%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Title
of each class</font></div>
</td>
<td style="vertical-align: bottom; width: 23%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Trading
Symbol(s)</font></div>
</td>
<td style="vertical-align: bottom; width: 40%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Name of
each exchange on which registered</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 37%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Common
Stock, $0.001 par value per share</font></div>
</td>
<td style="vertical-align: middle; width: 23%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">CELC</font></div>
</td>
<td style="vertical-align: middle; width: 40%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Nasdaq Stock Market LLC</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Indicate
by check mark whether the registrant is an emerging growth company
as defined in as defined in [sic] Rule 405 of the Securities Act of
1933 (&#xA7; 230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#xA7; 240.12b-2 of this
chapter).</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Emerging
growth company &#x2612;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. &#x2612;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 1px solid #000000; border-bottom: 4px solid #000000">
<!--style footer--><br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; break-after: page; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: rgb(255, 255, 255);">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 5.02&#xA0;Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px">On
December 3, 2019, the Board of Directors (&#x201C;<font style="text-decoration: underline">Board</font>&#x201D;) of Celcuity Inc.
(the &#x201C;<font style="text-decoration: underline">Company</font>&#x201D;) voted to elect
Richard E. Buller, M.D., Ph.D. as a new director. Dr. Buller joined
the Company's Board as an independent director, effective
immediately, for a term extending through the date of the Company's
next annual meeting of stockholders. Dr. Buller was not elected to
the Board pursuant to any arrangement or understanding between him
and any other person.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px">Upon
election to the Board and consistent with grants to other
non-employee directors, Dr. Buller was granted options to purchase
4,555 shares of the Company&#x2019;s common stock at an exercise
price of $10.68 per share, with such option shares vesting on the
earlier of April 30, 2020 or the date of the Company's next annual
meeting of stockholders. The estimated value of such grant was
approximately $31,930, which reflects a pro-rata portion of the
Company&#x2019;s annual director compensation. The Company expects
to make grants of similar value each year that Dr. Buller continues
to serve on the Board and intends to enter into an indemnification
agreement with Dr. Buller that is substantially similar to those
entered into by other members of the Board.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px">Other
than as described above, Dr. Buller has not been a party to, nor
has he had a direct or indirect material interest in, any
transactions with the Company during the current fiscal year or
prior fiscal years that would be reportable under Item 404(a) of
Regulation S-K.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 36px">
<font style="font-family: Times New Roman; font-size: 13px">On
December 5, 2019, the Company issued a press release announcing
this change to the Board. A copy of the press release is attached
hereto as Exhibit 99.1.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<a name="#item_1_47_1">&#xA0;</a></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 9.01&#xA0;Financial Statements and Exhibits.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">(d)&#xA0;Exhibits.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 96px">
<font style="font-family: Times New Roman; font-size: 13px"><a href="celc_ex991.htm">
99.1</a>&#xA0;Press Release of Celcuity Inc. dated December 5,
2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">2</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr"><br></div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SIGNATURES</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px;"><br>
</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="font-family: inherit; font-size: inherit; margin-right:0px;width:100%;margin-left:0px;">
<tr>
<td rowspan="1" style="width: 50%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 38%;">
<div><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">CELCUITY
INC.</font></div>
</td>
<td rowspan="1" style="width: 12%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="width: 50%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 3%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 35%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 12%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 50%; border-bottom: medium solid rgb(255, 255, 255);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-family: Times New Roman; font-size: 13px">Date: December 5,
2019</font></font></div>
</td>
<td style="vertical-align: top; width: 3%; border-bottom: medium solid rgb(255, 255, 255);">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">By:&#xA0;&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%; border-bottom: 2px solid black; white-space: nowrap;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">/s/ <font style="font-family: Times New Roman; font-size: 13px">Brian F.
Sullivan</font> &#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 12%; border-bottom: medium solid rgb(255, 255, 255);">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="width: 50%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 3%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 35%; white-space: nowrap;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-family: Times New Roman; font-size: 13px">Brian F.
Sullivan</font></font></div>
</td>
<td style="width: 12%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="width: 50%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 3%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="width: 35%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman"><font style="font-family: Times New Roman; font-size: 13px">Chairman and Chief
Executive Officer</font> &#xA0;</font></div>
</td>
<td style="width: 12%; vertical-align: top;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">3</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>celc_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2019 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;"><font style="font-weight: bold">
&#xA0;Exhibit 99.1</font><br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Celcuity Announces Appointment of Richard Buller to Board of
Directors</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Minneapolis,
Minnesota&#x2014;December 5, 2019 &#x2014;Celcuity Inc. (NASDAQ:
CELC) a functional cellular analysis company that is discovering
new cancer subtypes and commercializing diagnostic tests designed
to significantly improve clinical outcomes of cancer patients
treated with targeted therapies, today announced the appointment of
Richard Buller, M.D., Ph.D. to Celcuity&#x2019;s Board of Directors,
effective December 3, 2019.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div><font>&#xA0;</font></div>
<img src="celc_ex991000.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#x201C;We
are very pleased to have attracted Dr. Richard Buller, a proven
oncology drug development leader, to join our Board.
Richard&#x2019;s experience leading oncology clinical development
and translational medicine departments at major pharmaceutical
companies will provide a valuable perspective to Celcuity. He has
participated in the development of 15 drugs and several companion
diagnostics that received U.S. FDA approval, giving him a broad
perspective that is very relevant to Celcuity,&#x201D; said Brian F.
Sullivan, Chairman and Chief Executive Officer of
Celcuity.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dr.
Buller most recently served as Head Oncology Clinical Development
and Vice President of Translational Oncology at Pfizer, Inc., one
of the world&#x2019;s largest pharmaceutical companies, until he
retired in 2016. He had previously served as Vice President of
Translational Medicine at Exelixis, a leading biopharmaceutical
company, where he led efforts to study patients selected by
molecular testing for inclusion in their phase 2 and phase 3
clinical trials. He began his pharmaceutical company career at
GlaxoSmithKline as Director of the Oncology Medicine Development
Center. Prior to his leadership positions in drug development, he
was Professor of Gynecologic Oncology at the University of Iowa,
where he led laboratory research focused on identifying genomic
variants involved in ovarian cancer. He received his M.D. from the
Baylor College of Medicine, where he also received his Ph.D. in
cell biology.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #231F20; font-weight: bold; font-family: Times New Roman; font-size: 13px">
About Celcuity</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #231F20">
Celcuity is a functional cellular analysis company that is
discovering new cancer subtypes and commercializing diagnostic
tests designed to significantly improve the clinical outcomes of
cancer patients treated with targeted therapies.&#xA0;
Celcuity&#x2019;s proprietary CELx diagnostic platform uses a
patient&#x2019;s living tumor cells to identify the specific
abnormal cellular activity driving a patient&#x2019;s cancer and the
targeted therapy that can best treat that patient&#x2019;s disease.
Celcuity is headquartered in Minneapolis, Minnesota. Further
information about Celcuity can be found at</font> <font style="text-decoration: underline; color: #0563C1">www.celcuity.com</font>.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #231F20; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #231F20; font-family: Times New Roman; font-size: 13px">
Forward-Looking Statements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #231F20; font-family: Times New Roman; font-size: 13px">
This press release contains statements that constitute
&#x201C;forward-looking statements,&#x201D; including the anticipated
benefits to the clinical outcomes of cancer patients.
Forward-looking statements are subject to numerous conditions, many
of which are beyond the control of Celcuity, which include, but are
not limited to, those set forth in the Risk Factors section of
Celcuity&#x2019;s Annual Report on Form 10-K for the year ended
December 31, 2018. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date hereof. Celcuity undertakes no obligation to update
these statements for revisions or changes after the date of this
release, except as required by law.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Contacts:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Celcuity
Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Brian
Sullivan, bsullivan@celcuity.com</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Vicky
Hahne, vhahne@celcuity.com</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>celc_ex991000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 celc_ex991000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !' -T# 2(  A$! Q$!_\0
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MFN9]3&@\*:#:ZS'J]MI5K!?QJRK-"FPX(P<@<&K^I7T6F:9=7\Q_=6T+2O\
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MX<_Z^W_DM>Q+]T?2O'?C[_QZ^'/^OM_Y+7L2_='TK2?\./S(C\;%KQGX;?\
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M\4\<1MX#^+&E^+8%*V&H-Y=V .,\*_YKAOJIKVNO.OC9)IR?#R9;WF=IT^R
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M'D@'\JD'B308=:70AJ5JFH8 6U#8(XR!Z9QSCK6L9<JT6I$H\SU>AK !0
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M^$0.GVT1EN-3NH;)(]P7?O8$C)X&5!&3ZUP=Q!)+\+-4T"\MC:_8]<CMC )
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8]B<GT%%%-15W\_S!MV7R/7****Y#H/_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
